Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Inclusion Criteria

• •Less than 18 years at the time of anticipated transplant
• •Participant meets one of the following criteria:
• •1. scheduled to receive allogeneic hematopoietic cell transplant within 14 days of enrollment or
• •2. Scheduled to or received solid organ transplant within 7 days before or after enrollment
• •Participant is receiving care at the time of enrollment at one of the study participating institutions.
• •Parent/guardian willing and able to provide informed consent, and if appropriate, child willing and able to provide informed assent.
• •Donor for HCT recipient enrolled on the VIPER study.
• •Willing and able to provide informed consent.